Chronic kidney disease (CKD) is a public health epidemic that increases risk of death due to cardiovascular disease. Left ventricular hypertrophy (LVH) is an important mechanism of cardiovascular disease in individuals with CKD. Elevated levels of FGF23 have been linked to greater risks of LVH and mortality in patients with CKD, but whether these risks represent causal effects of FGF23 is unknown. Here, we report that elevated FGF23 levels are independently associated with LVH in a large, racially diverse CKD cohort. FGF23 caused pathological hypertrophy of isolated rat cardiomyocytes via FGF receptor–dependent activation of the calcineurin-NFAT signaling pathway, but this effect was independent of klotho, the coreceptor for FGF23 in the kidney and parathyroid glands. Intramyocardial or intravenous injection of FGF23 in wild-type mice resulted in LVH, and klotho-deficient mice demonstrated elevated FGF23 levels and LVH. In an established animal model of CKD, treatment with an FGF–receptor blocker attenuated LVH, although no change in blood pressure was observed. These results unveil a klotho-independent, causal role for FGF23 in the pathogenesis of LVH and suggest that chronically elevated FGF23 levels contribute directly to high rates of LVH and mortality in individuals with CKD.
Christian Faul, Ansel P. Amaral, Behzad Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mundel, Azorides Morales, Julia Scialla, Michael Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro-o, John W. Kusek, Martin G. Keane, Myles Wolf
Title and authors | Publication | Year |
---|---|---|
CKD-Induced Wingless/Integration1 Inhibitors and Phosphorus Cause the CKD-Mineral and Bone Disorder
Y Fang, C Ginsberg, M Seifert, O Agapova, T Sugatani, TC Register, BI Freedman, MC Monier-Faugere, H Malluche, KA Hruska |
Journal of the American Society of Nephrology : JASN | 2014 |
Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
MC Hu, M Shi, HJ Cho, B Adams-Huet, J Paek, K Hill, J Shelton, AP Amaral, C Faul, M Taniguchi, M Wolf, M Brand, M Takahashi, M Kuro-o, JA Hill, OW Moe |
Journal of the American Society of Nephrology : JASN | 2014 |
Knockout of Nuclear High Molecular Weight FGF2 Isoforms in Mice Modulates Bone and Phosphate Homeostasis
C Homer-Bouthiette, T Doetschman, L Xiao, MM Hurley |
The Journal of biological chemistry | 2014 |
Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?
TM Vo, S Disthabanchong |
World journal of cardiology | 2014 |
Vitamin D and chronic kidney disease
CS Kim, SW Kim |
The Korean Journal of Internal Medicine | 2014 |
Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population: The Multi-Ethnic Study of Atherosclerosis
B Kestenbaum, MC Sachs, AN Hoofnagle, DS Siscovick, JH Ix, C Robinson-Cohen, JA Lima, JF Polak, M Blondon, J Ruzinski, D Rock, IH de Boer |
Circulation. Heart failure | 2014 |
S100/Calgranulin-Mediated Inflammation Accelerates Left Ventricular Hypertrophy and Aortic Valve Sclerosis in Chronic Kidney Disease in a Receptor for Advanced Glycation End Products-Dependent Manner
L Yan, L Mathew, B Chellan, B Gardner, J Earley, TS Puri, MA Bowman |
Arteriosclerosis, thrombosis, and vascular biology | 2014 |
Biomarkers of Vascular Calcification and Mortality in Patients with ESRD
JJ Scialla, WH Kao, C Crainiceanu, SM Sozio, PC Oberai, T Shafi, J Coresh, NR Powe, LC Plantinga, BG Jaar, RS Parekh |
Clinical journal of the American Society of Nephrology : CJASN | 2014 |
FGF23 regulates renal sodium handling and blood pressure
O Andrukhova, S Slavic, A Smorodchenko, U Zeitz, V Shalhoub, B Lanske, EE Pohl, RG Erben |
EMBO Molecular Medicine | 2014 |
Treatment of phosphate retention: The earlier the better?
P Biggar, SK Fung, M Ketteler |
Kidney Research and Clinical Practice | 2014 |
Therapeutic management of hypophosphatemic rickets from infancy to adulthood
A Linglart, M Biosse-Duplan, K Briot, C Chaussain, L Esterle, S Guillaume-Czitrom, P Kamenicky, J Nevoux, D Prié, A Rothenbuhler, P Wicart, P Harvengt |
Endocrine Connections | 2014 |
Hypophosphatemic Rickets: Revealing Novel Control Points for Phosphate Homeostasis
KE White, JM Hum, MJ Econs |
Current Osteoporosis Reports | 2014 |
Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models
N Su, M Jin, L Chen |
Bone Research | 2014 |
The role of bone in CKD-mediated mineral and vascular disease
NM Khouzam, K Wesseling-Perry, IB Salusky |
Pediatric Nephrology | 2014 |
Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease
JJ Scialla, M Wolf |
Nature Reviews Nephrology | 2014 |
Fibroblast growth factor 23 in acute kidney injury:
M Christov |
Current Opinion in Nephrology and Hypertension | 2014 |
What can FGF23 do without Klotho?
S Fukumoto |
BoneKEy Reports | 2014 |
The Use of Fibroblast Growth Factor 23 Testing in Patients with Kidney Disease
ER Smith |
Clinical journal of the American Society of Nephrology : CJASN | 2014 |
Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
S Seiler, KS Rogacev, HJ Roth, P Shafein, I Emrich, S Neuhaus, J Floege, D Fliser, GH Heine |
Clinical journal of the American Society of Nephrology : CJASN | 2014 |
FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis
LM Coe, SV Madathil, C Casu, B Lanske, S Rivella, D Sitara |
The Journal of biological chemistry | 2014 |
Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
J Xie, J Yoon, SW An, M Kuro-o, CL Huang |
Journal of the American Society of Nephrology : JASN | 2014 |
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease
J Tuñón, C Cristóbal, N Tarín, Á Aceña, ML González-Casaus, A Huelmos, J Alonso, Ó Lorenzo, E González-Parra, I Mahíllo-Fernández, AM Pello, R Carda, J Farré, F Rodríguez-Artalejo, L López-Bescós, J Egido, C Pizzi |
PloS one | 2014 |
Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium
I Six, H Okazaki, P Gross, J Cagnard, C Boudot, J Maizel, TB Drueke, ZA Massy, M Bader |
PloS one | 2014 |
Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease
R Jimbo, T Shimosawa |
International Journal of Hypertension | 2014 |
Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD
LN Zhang, G Yang, C Cheng, C Shen, YY Cui, J Zhang, JJ Zhang, ZX Shen, M Zeng, YF Ge, B Sun, XB Yu, C Ouyang, B Zhang, HJ Mao, J Liu, CY Xing, XM Zha, NN Wang |
Osteoporosis International | 2014 |
Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease
S Goto, K Nakai, K Kono, Y Yonekura, J Ito, H Fujii, S Nishi |
Clinical and Experimental Nephrology | 2014 |
Novel targets of antifibrotic and anti-inflammatory treatment in CKD
AE Declèves, K Sharma |
Nature Reviews Nephrology | 2014 |
Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease
YA Hong, JH Lim, MY Kim, Y Kim, KS Yang, BH Chung, S Chung, BS Choi, CW Yang, YS Kim, YS Chang, CW Park |
Clinical and Experimental Nephrology | 2014 |
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease
M Wolf, KE White |
Current Opinion in Nephrology and Hypertension | 2014 |
Serum Phosphorus and Mortality in the Third National Health and Nutrition Examination Survey (NHANES III): Effect Modification by Fasting
AR Chang, ME Grams |
American Journal of Kidney Diseases | 2014 |
Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats
N Arai-Nunota, M Mizobuchi, H Ogata, A Yamazaki-Nakazawa, C Kumata, F Kondo, N Hosaka, F Koiwa, E Kinugasa, T Shibata, T Akizawa |
PloS one | 2014 |
Heart Failure in Patients with Chronic Kidney Disease: A Systematic Integrative Review
L Segall, I Nistor, A Covic |
BioMed Research International | 2014 |
Coronary artery calcification in chronic kidney disease: An update
T Stompór |
World journal of cardiology | 2014 |
Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients
N Chitalia, T Ismail, L Tooth, F Boa, G Hampson, D Goldsmith, JC Kaski, D Banerjee |
PloS one | 2014 |
Optimization of Bone Health in Children before and after Renal Transplantation: Current Perspectives and Future Directions
K Sgambat, A Moudgil |
Frontiers in Pediatrics | 2014 |
Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism
H Sakan, K Nakatani, O Asai, A Imura, T Tanaka, S Yoshimoto, N Iwamoto, N Kurumatani, M Iwano, YI Nabeshima, N Konishi, Y Saito |
PloS one | 2014 |
Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
GS di Marco, S Reuter, D Kentrup, A Grabner, AP Amaral, M Fobker, J Stypmann, H Pavenstadt, M Wolf, C Faul, M Brand |
Nephrology Dialysis Transplantation | 2014 |
Association of fibroblast growth factor-23 with arterial stiffness in the Multi-Ethnic Study of Atherosclerosis
JJ Hsu, R Katz, JH Ix, IH de Boer, B Kestenbaum, MG Shlipak |
Nephrology Dialysis Transplantation | 2014 |
The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study
D Hansen, K Rasmussen, LM Rasmussen, H Bruunsgaard, L Brandi |
BMC Nephrology | 2014 |
Novel metabolic biomarkers of cardiovascular disease
MK Jensen, ML Bertoia, LE Cahill, I Agarwal, EB Rimm, KJ Mukamal |
Nature Reviews Endocrinology | 2014 |
Intersection of cardiovascular disease and kidney disease: atrial fibrillation
N Bansal, C Hsu, AS Go |
Current Opinion in Nephrology and Hypertension | 2014 |
A Comparison of Calcium to Zoledronic Acid for Improvement of Cortical Bone in an Animal Model of CKD: CALCIUM VS ZOLEDRONIC ACID IN CORTICAL BONE IN AN ANIMAL MODEL OF CKD
SM Moe, NX Chen, CL Newman, VH Gattone, JM Organ, X Chen, MR Allen |
Journal of Bone and Mineral Research | 2014 |
Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?
A Bellasi, BR di Iorio |
Nephro-Urology Monthly | 2014 |
FGF23 protein expression in coronary arteries is associated with impaired kidney function
NA van Venrooij, RC Pereira, Y Tintut, MC Fishbein, N Tumber, LL Demer, IB Salusky, K Wesseling-Perry |
Nephrology Dialysis Transplantation | 2014 |
Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
JA Udell, DA Morrow, P Jarolim, S Sloan, EB Hoffman, TF O'Donnell, AN Vora, T Omland, SD Solomon, MA Pfeffer, E Braunwald, MS Sabatine |
Journal of the American College of Cardiology | 2014 |
Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study
PS Garimella, JH Ix, R Katz, MB Chonchol, BR Kestenbaum, IH de Boer, DS Siscovick, S Shastri, JS Hiramoto, MG Shlipak, MJ Sarnak |
Atherosclerosis | 2014 |
Left Ventricular Mass Progression despite Stable Blood Pressure and Kidney Function in Stage 3 Chronic Kidney Disease
ME Seifert, L las Fuentes, C Ginsberg, M Rothstein, DJ Dietzen, SC Cheng, W Ross, D Windus, VG Dávila-Román, KA Hruska |
American Journal of Nephrology | 2014 |
The bone kidney axis:
M Baum |
Current Opinion in Pediatrics | 2014 |
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study
EJ Bernstein, T Isakova, ME Sullivan, LB Chibnik, M Wolf, J Kay |
Rheumatology | 2014 |
Endocrine Crosstalk Between Muscle and Bone
M Brotto, ML Johnson |
Current Osteoporosis Reports | 2014 |
Fibroblast Growth Factor-23 in Obese, Normotensive Adolescents Is Associated with Adverse Cardiac Structure
FN Ali, B Falkner, SS Gidding, HE Price, SW Keith, CB Langman |
The Journal of Pediatrics | 2014 |
Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients
M Ozeki, SI Fujita, S Kizawa, H Morita, K Sohmiya, M Hoshiga, N Ishizaka |
BMC Nephrology | 2014 |
Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial
P Ureña-Torres, D Prié, K Keddad, P Preston, P Wilde, H Wan, JB Copley |
BMC Nephrology | 2014 |
Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling
S Seigneux, M Courbebaisse, JM Rutkowski, A Wilhelm-Bals, M Metzger, SN Khodo, U Hasler, H Chehade, E Dizin, A Daryadel, B Stengel, E Girardin, D Prie, CA Wagner, PE Scherer, PY Martin, P Houillier, E Feraille |
2014 | |
Left Ventricular Hypertrophy and Chronic Renal Insufficiency in the Elderly
D Leibowitz |
Cardiorenal Medicine | 2014 |
Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins: Cardiorenal syndrome
S Lekawanvijit, H Krum |
The Journal of Physiology | 2014 |
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial
G Fuernau, J Pöss, D Denks, S Desch, GH Heine, I Eitel, S Seiler, S Waha, S Ewen, A Link, G Schuler, V Adams, M Böhm, H Thiele |
Critical Care | 2014 |
Fibroblast growth factor 23 and acute kidney injury
JA Neyra, OW Moe, MC Hu |
Pediatric Nephrology | 2014 |
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease:
D Charytan |
Current Opinion in Nephrology and Hypertension | 2014 |
Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivo
RC Pereira, AM Delany, NM Khouzam, RE Bowen, EG Freymiller, IB Salusky, K Wesseling-Perry |
Kidney International | 2014 |
Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
AL Negri, PA Torres |
Clinical Kidney Journal | 2014 |
Elevated Cardiac Markers in Chronic Kidney Disease as a Consequence of Hyperphosphatemia-Induced Cardiac Myocyte Injury
A Peng |
Medical science monitor : international medical journal of experimental and clinical research | 2014 |
Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
R Giuseppe, T Kühn, F Hirche, B Buijsse, J Dierkes, A Fritsche, R Kaaks, H Boeing, GI Stangl, C Weikert |
European Journal of Epidemiology | 2014 |
Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry
K Eckberg, H Kramer, M Wolf, R Durazo-Arvizu, B Tayo, A Luke, R Cooper |
Nephrology Dialysis Transplantation | 2014 |
Serum Parathyroid Hormone and 25-Hydroxyvitamin D Concentrations and Risk of Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis
N Bansal, L Zelnick, C Robinson-Cohen, AN Hoofnagle, JH Ix, JA Lima, AB Shoben, CA Peralta, DS Siscovick, B Kestenbaum, IH de Boer |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2014 |
Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
DC Wheeler, GM London, PS Parfrey, GA Block, R Correa-Rotter, B Dehmel, TB Drueke, J Floege, Y Kubo, KW Mahaffey, WG Goodman, SM Moe, ML Trotman, S Abdalla, GM Chertow, CA Herzog |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2014 |
Why do young people with chronic kidney disease die early?
S Kumar |
World Journal of Nephrology | 2014 |
Circulating Fibroblast Growth Factor-23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
A Alonso, JR Misialek, JH Eckfeldt, E Selvin, J Coresh, LY Chen, EZ Soliman, SK Agarwal, PL Lutsey |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2014 |
Fibroblast Growth Factor-23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
PL Lutsey, A Alonso, E Selvin, JS Pankow, ED Michos, SK Agarwal, LR Loehr, JH Eckfeldt, J Coresh |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2014 |
Cardiovascular Events after AKI: A New Dimension
C Hsu, KD Liu |
Journal of the American Society of Nephrology : JASN | 2014 |
Pathogenesis of Arrhythmias in a Model of CKD
CH Hsueh, NX Chen, SF Lin, PS Chen, VH Gattone, MR Allen, MC Fishbein, SM Moe |
Journal of the American Society of Nephrology : JASN | 2014 |
Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study
JH Ix, CA Anderson, G Smits, MS Persky, GA Block |
The American journal of clinical nutrition | 2014 |
Fibroblast Growth Factor 23 and Incident CKD in Type 2 Diabetes
T Isakova, TE Craven, J Lee, JJ Scialla, H Xie, P Wahl, SM Marcovina, RP Byington, M Wolf |
Clinical journal of the American Society of Nephrology : CJASN | 2014 |
The Biomarker Niche for Fibroblast Growth Factor 23 Testing in CKD
M Wolf |
Journal of the American Society of Nephrology : JASN | 2014 |
Serum Fibroblast Growth Factor-23 Is Associated with Incident Kidney Disease
CM Rebholz, ME Grams, J Coresh, E Selvin, LA Inker, AS Levey, PL Kimmel, RS Vasan, JH Eckfeldt, HI Feldman, C Hsu, PL Lutsey |
Journal of the American Society of Nephrology : JASN | 2014 |
Arterial Stiffness, Central Pressures, and Incident Hospitalized Heart Failure in the Chronic Renal Insufficiency Cohort Study
JA Chirinos, A Khan, N Bansal, DL Dries, HI Feldman, V Ford, AH Anderson, R Kallem, JP Lash, A Ojo, M Schreiber, A Sheridan, J Strelsin, V Teal, J Roy, Q Pan, AS Go, RR Townsend |
Circulation. Heart failure | 2014 |
FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
N Silswal, CD Touchberry, DR Daniel, DL McCarthy, S Zhang, J Andresen, JR Stubbs, MJ Wacker |
American journal of physiology. Endocrinology and metabolism | 2014 |
Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study
PL Lutsey, A Alonso, ED Michos, LR Loehr, BC Astor, J Coresh, AR Folsom |
The American journal of clinical nutrition | 2014 |
Fibroblast Growth Factor 23: A Novel Key to Find Hidden Substrates of Atrial Fibrillation?
A Kalyanasundaram, VV Fedorov |
Circulation | 2014 |
Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)
JS Mathew, MC Sachs, R Katz, KK Patton, SR Heckbert, AN Hoofnagle, A Alonso, M Chonchol, R Deo, JH Ix, DS Siscovick, B Kestenbaum, IH de Boer |
Circulation | 2014 |
In Search of the Fountain of Youth
M Wolf |
Journal of the American Society of Nephrology : JASN | 2014 |
Plasma FGF23 and the risk of stroke: The Northern Manhattan Study (NOMAS)
CB Wright, C Dong, M Stark, S Silverberg, T Rundek, MS Elkind, RL Sacco, A Mendez, M Wolf |
Neurology | 2014 |
Speckle Tracking Echocardiography Detects Uremic Cardiomyopathy Early and Predicts Cardiovascular Mortality in ESRD
R Kramann, J Erpenbeck, RK Schneider, AB Rohl, M Hein, VM Brandenburg, M Diepen, F Dekker, N Marx, J Floege, M Becker, G Schlieper |
Journal of the American Society of Nephrology : JASN | 2014 |
Competitive Interaction Between Fibroblast Growth Factor 23 And Asymmetric Dimethylarginine in Patients With CKD
G Tripepi, B Kollerits, D Leonardis, MI Yilmaz, M Postorino, D Fliser, F Mallamaci, F Kronenberg, C Zoccali |
Journal of the American Society of Nephrology : JASN | 2014 |
Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD
ED Labonte, CW Carreras, MR Leadbetter, K Kozuka, J Kohler, S Koo-McCoy, L He, E Dy, D Black, Z Zhong, I Langsetmo, AG Spencer, N Bell, D Deshpande, M Navre, JG Lewis, JW Jacobs, D Charmot |
Journal of the American Society of Nephrology : JASN | 2014 |
Klotho Deficiency and the Cardiomyopathy of Advanced CKD
J Floege, D Fliser |
Journal of the American Society of Nephrology : JASN | 2014 |
Fibroblast Growth Factor–23 and Cardiac Structure and Function
I Agarwal, N Ide, J H., B Kestenbaum, B Lanske, NB Schiller, MA Whooley, KJ Mukamal |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2014 |
Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study.
Kovács A, Tapolyai M, Celeng C, Gara E, Faludi M, Berta K, Apor A, Nagy A, Tislér A, Merkely B |
The International Journal of Cardiovascular Imaging | 2014 |
Chronic sustained inflammation links to left ventricular hypertrophy and aortic valve sclerosis: a new link between S100/RAGE and FGF23
Yan L, Bowman MA |
Inflammation and Cell Signaling | 2014 |
Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
Okamoto Y, Fujita S, Morita H, Kizawa S, Ito T, Sakane K, Sohmiya K, Hoshiga M, Ishizaka N |
Heart and Vessels | 2014 |
Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.
Palazzuoli A, Masson S, Ronco C, Maisel A |
Heart Failure Reviews | 2014 |